Innocan Pharma announced the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the ...
Read More »Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD
InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...
Read More »